Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuropsychiatric Adverse Effects of Efavirenz in Children Living With HIV in Kilimanjaro, Tanzania

NCT03227653 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT03227653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03227653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuropsychiatric Adverse Effects of Efavirenz in Children Living With HIV in Kilimanjaro, Tanzania
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
June 19, 2017
Completion date
December 31, 2017
Enrollment
144 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

child behavior, cognitive symptom, drug-related side effects and adverse reactions, efavirenz, medication adherence